| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 3,589,000 | 3,245,000 | 3,127,000 | 4,082,000 | | Cost of Revenue | 2,065,000 | 1,957,000 | 1,888,000 | 2,693,000 | | | Gross Profit | 1,524,000 | 1,288,000 | 1,239,000 | 1,389,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,024,000 | 913,000 | 886,000 | 991,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 500,000 | 375,000 | 353,000 | 398,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 2,000 | 2,000 | 4,000 | | Earnings Before Interest And Taxes | 501,000 | 377,000 | 355,000 | 402,000 | | Interest Expense | 1,000 | 1,000 | 2,000 | 1,000 | | Income Before Tax | 500,000 | 376,000 | 353,000 | 401,000 | | Income Tax Expense | 193,000 | 148,000 | 138,000 | 158,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 307,000 | 228,000 | 215,000 | 243,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 307,000 | 228,000 | 215,000 | 243,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $307,000 | $228,000 | $215,000 | $243,000 |
|
1.52% Nasdaq 0.00%
Income Statement
